Competitor Analysis: Cardiovascular Peptides
Competitor Analysis: Cardiovascular Peptides
The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, peripheral vascular diseases, hemostasis and wound sealing provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of current active projects in research and development of cardiovasuclar peptides. In addition, the report lists company-specific R&D pipelines of cardiovascular peptides. Competitor projects are listed in a tabular format providing information on:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, peripheral vascular diseases, hemostasis and wound sealing provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of current active projects in research and development of cardiovasuclar peptides. In addition, the report lists company-specific R&D pipelines of cardiovascular peptides. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
2013 Sales of Major Cardiovascular Peptides
Acute Care & Reperfusion Injuries
Heart Failure
Coronary Ischemia & Myocardial Infarction
Cardiometabolic Disease & Atherosclerosis
Peripheral Vascular Disease
Hypertension
Pulmonary Artery Hypertension
Hemostasis, Wound Sealing & Prevention of Thrombosis
Hematologic Diseases
Corporate Cardiovascular Peptide R&D Pipelines
Acute Care & Reperfusion Injuries
Heart Failure
Coronary Ischemia & Myocardial Infarction
Cardiometabolic Disease & Atherosclerosis
Peripheral Vascular Disease
Hypertension
Pulmonary Artery Hypertension
Hemostasis, Wound Sealing & Prevention of Thrombosis
Hematologic Diseases
Corporate Cardiovascular Peptide R&D Pipelines
